Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Controlled Study to Evaluate the Efficacy of Allogeneic MesenCure for the Treatment of Patients With ARDS

NCT05497401 is registered in ClinicalTrials.gov with BonusBio Group Ltd as lead sponsor.

NCT NCT05497401
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05497401 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Controlled Study to Evaluate the Efficacy of Allogeneic MesenCure for the Treatment of Patients With ARDS
Lead sponsor
BonusBio Group Ltd
Phase
Phase 3
Overall status
Not yet recruiting
Start date
April 30, 2026
Completion date
October 31, 2028
Enrollment
300 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

ards